|Bid||4.6700 x 800|
|Ask||4.6800 x 2200|
|Day's Range||4.5800 - 4.9250|
|52 Week Range||2.3100 - 11.5950|
|Beta (5Y Monthly)||1.96|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 14, 2022 - Nov 18, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Subscribe to Yahoo Finance Plus to view Fair Value for BFLY
BURLINGTON, Mass. & NAIROBI, Kenya, September 20, 2022--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care through the power of handheld, whole-body ultrasound and connected medicine, today announced the deployment of 500 Butterfly iQ+ devices to healthcare practitioners in Kenya, at a ceremony at Kenyatta University. This deployment is supported by a $5 million grant from the Bill & Melinda Gates Foundation announced earlier this year that will provide 1,000 health
Growth stocks associated with innovative healthcare businesses aren't getting the positive attention they deserve. At least that's what Cathie Wood's recent purchases suggest. Recently, the CEO of ARK Investment Management added heavily to Exact Sciences (NASDAQ: EXAS), CareDx (NASDAQ: CDNA), and Butterfly Network (NYSE: BFLY).
The growth investor that became a rock star after a market-thumping run in 2020 as the co-founder and CEO of the Ark Invest exchange-traded funds (ETFs) has seen many of her key investments falter over the past year and change. Exact Sciences was a market darling for Wood in 2020, but it's been largely downhill since the stock peaked early last year.